Skip to content

Comparative Evaluation of Phacoemulsification with Goniosynechialysis and Phacoemulsification with Viscogonioplasty in Angle-Closure Glaucoma: A Randomized Clinical Trial

Comparative Evaluation of Phacoemulsification with Goniosynechialysis and Phacoemulsification with Viscogonioplasty in Angle-Closure Glaucoma: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240805005
Enrollment
68
Registered
2024-08-05
Start date
2021-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To compare effectiveness of Phacoemulsification with goniosynechialysis and Phacoemulsification with viscogoniosynechialysis in Angle-Closure Glaucoma goniosynechialysis viscogoniosynechialysis Angle-Closure PACG acute angle closure attack

Interventions

Phacoemulsification was performed with two side-port incisions and a 2.7 mm temporal clear corneal incision. The phaco-chop technique was used, and an intraocular lens was implanted in the bag. Cohesi
TRB CHEMEDICA, Geneva, Switzerland) was utilized during the procedure. A phacoemulsification machine (Centurion
Alcon Laboratories Inc., Fort Worth, TX) was used in all cases. Postoperatively, topical antibiotics and steroids were prescribed to all patients, with the steroids being tapered off over a period of
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Phacoemulsification with Gonisynechialysis,Phacoemulsification with Viscogonioplasty

Sponsors

No Dechathon Asanathong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) patients with angle closure defined by the presence of iridotrabecular contact of at least 180 degrees, which can be either appositional or synechial. 2) patients with visually significant cataract with visual acuity worse than 20/50.

Exclusion criteria

Exclusion criteria: 1) presence or history of any cause of secondary glaucoma, including traumatic glaucoma, uveitic glaucoma, neovascular glaucoma, phacomorphic glaucoma, and pseudoexfoliation glaucoma 2) history of previous intraocular surgery.

Design outcomes

Primary

MeasureTime frame
Type of glaucoma medication 6 month pair Ttest,Intraocular pressure 6 month pair t test

Secondary

MeasureTime frame
Ocular parameter 3 month pair t test

Countries

Thailand

Contacts

Public ContactDechathon Asanathong

Sisaket Hospital

dr.deacha@gmail.com0898460208

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026